Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

$37.2M

Market Cap • 11/18/2024

2001

(23 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of AU

Sydney

Headquarters • NSW